A detailed history of Captrust Financial Advisors transactions in Zomedica Corp. stock. As of the latest transaction made, Captrust Financial Advisors holds 24,615 shares of ZOM stock, worth $3,446. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,615
Holding current value
$3,446
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.12 - $0.16 $2,953 - $3,938
24,615 New
24,615 $3,000
Q2 2022

Aug 16, 2022

BUY
$0.2 - $0.34 $200 - $340
1,000 Added 13.33%
8,500 $2,000
Q4 2021

Feb 14, 2022

SELL
$0.31 - $0.58 $1,240 - $2,320
-4,000 Reduced 34.78%
7,500 $2,000
Q3 2021

Nov 16, 2021

SELL
$0.46 - $0.81 $23,000 - $40,500
-50,000 Reduced 81.3%
11,500 $6,000
Q2 2021

Aug 16, 2021

BUY
$0.72 - $1.46 $38,160 - $77,380
53,000 Added 623.53%
61,500 $51,000
Q1 2021

May 17, 2021

BUY
$0.35 - $2.7 $2,975 - $22,950
8,500 New
8,500 $13,000

Others Institutions Holding ZOM

About Zomedica Corp.


  • Ticker ZOM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 979,950,016
  • Market Cap $137M
  • Description
  • Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...
More about ZOM
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.